October 12th, 2023
Harvard enters into Collaboration with Novo Nordisk and Evotec to launch LAB eN², a translational drug discovery accelerator
Harvard University joins Mass General Brigham, Yale University, and Beth Israel Deaconess Medical Center as the initial four academic institutions to participate in LAB eN².
